Effect of the ABO Gene Variant c.917T>C on the Expression and Functional Role of B-Glycosyltransferase.
10.19746/j.cnki.issn.1009-2137.2025.01.040
- Author:
Shuang LIANG
1
;
Fan WU
1
;
Yan-Lian LIANG
1
;
Tong LIU
1
;
Li-Yan SUN
1
;
Yu-Qing SU
1
Author Information
1. Shenzhen Blood Center, Shenzhen 518040, Guangdong Province, China.
- Publication Type:Journal Article
- Keywords:
ABO blood group;
mutant;
expression
- MeSH:
Humans;
ABO Blood-Group System/genetics*;
Alleles;
Genotype;
Mutation;
Glycosyltransferases/genetics*;
Haplotypes;
Phenotype
- From:
Journal of Experimental Hematology
2025;33(1):269-275
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:By analyzing the correlation between genotypes and phenotypes, we explored the impact of the variant c.917T>C (p.L306P) in the ABO*B.01 allele on the expression and function of B-glycosyltransferase (GTB). This study aims to elucidate the molecular mechanisms underlying the occurrence of this subtype.
METHODS:The study subjects included a blood donor specimen with incompatible forward and reverse ABO typing results. ABO phenotyping was determined using ABO blood group serology and GTB activity testing. Subsequently, Sanger sequencing and third-generation sequencing based on the PacBio platform were employed to sequence the ABO gene, resulting in the determination of haplotype sequences. Mutations were identified through sequence alignment. An in vitro cell expression system was established to assess the impact of the mutation site on antigen expression.
RESULTS:The index case in this study was identified as B subtype with the allelic genotype c.917T>C in ABO*B.01/ABO*O.01.01 , which has not been previously reported. in vitro expression results revealed decreased levels of GTB expression and overall GTB activity in the mutant cells. Furthermore, the expression of the B antigen on the cell membrane was weaker in the mutant cells compared to the wild-type cells.
CONCLUSION:The p.L306P variation caused by the c.917T>C mutation in the ABO*B.01 allele may be a genetic factor contributing to the reduced expression of B antigens on the surface of red blood cells.
